does tirzepatide interact with any medications what drugs It's important to study the difference in GLP-1 medications. Tirzepatide gene–disease phenotype–drug response interaction
Description
The FDA has also placed a warning on tirzepatide that anyone with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasias should not take it
How does Tirzepatide differ from Semaglutide

Are there any dietary restrictions I should follow while taking this medication

Supports cellular repair and recovery

Will keep using

Mechanism of Action Comparison# Retatrutide# Retatrutide (LY3437943) is a 39-amino acid peptide that simultaneously activates three metabolically important receptors: GLP-1 receptor : Enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes central satiety signaling GIP receptor : Potentiates insulin secretion, may improve beta-cell function, and contributes to adipose tissue metabolism Glucagon receptor : Increases hepatic glucose output acutely but chronically promotes hepatic fat oxidation, thermogenesis, and energy expenditure The glucagon receptor component distinguishes retatrutide from all other approved or late-stage metabolic peptides